Salah-Eddin Al-Batran, Director Institute of Clinical Research UCT-University Cancer Center, shared a post on LinkedIn:
“I’m delighted to welcome our European colleagues to the EUCAN Preceptorship on Gastroesophageal Cancers, taking place in the Lindner Hotel Main Plaza, Frankfurt am Main, over the next two days and funded by AstraZeneca.
Together, we will dive deep into the treatment and research landscape for both early and advanced-stage disease.“
Source: Salah-Eddin Al-Batran/LinkedIn